A cost minimisation analysis of navelbine-cisplatin versus gemcitabine-cisplatin in advanced nonsmall cell lung cancer in Poland

被引：0
|
作者：
Skowron, A. [1 ]
Polak, S. [1 ]
Brandys, J. [1 ]
机构：
[1] Jagiellonian Univ, Krakow, Malopolska, Poland
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63461-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A285 / A285
页数：1
相关论文
共 50 条
  • [31] A comparative study of combination chemotherapy with docetaxel/cisplatin versus gemcitabine/cisplatin for locally advanced non-small cell lung cancer
    El-Nashar, E
    LUNG CANCER, 2005, 49 : S243 - S243
  • [32] Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
    Crino, L
    Seagliotti, G
    Marangolo, M
    Figoli, F
    Clerici, M
    DeMarinis, F
    Salvati, F
    Cruciani, G
    Dogliotti, L
    Cocconi, G
    Paccagnella, A
    Adamo, V
    Incoronato, P
    Scarcella, L
    Mosconi, AM
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1064 - 1064
  • [33] Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer
    J. R. Kroep
    E. F. Smit
    G. Giaccone
    K. Van der Born
    J. H. Beijnen
    C. J. Van Groeningen
    W. J. F. Van der Vijgh
    P. E. Postmus
    H. M. Pinedo
    G. J. Peters
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 509 - 516
  • [34] A study of gemcitabine-cisplatin vs paclitaxel-carboplatin chemotherapy in patients with advanced squamous cell carcinoma of the lung
    Rajan, T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S74 - S74
  • [35] CISPLATIN, 5-FLUOROURACIL, AND ETOPOSIDE FOR ADVANCED NONSMALL CELL LUNG-CANCER
    LYNCH, TJ
    KASS, F
    KALISH, LA
    ELIAS, AD
    STRAUSS, G
    SHULMAN, LN
    SUGARBAKER, DJ
    SKARIN, A
    FREI, E
    CANCER, 1993, 71 (10) : 2953 - 2957
  • [36] Gemcitabine plus cisplatin in advanced non small cell lung cancer (NSCLC)
    Casal, J
    Huidobro, G
    Grande, C
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [37] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [38] FOLFIRINOX versus gemcitabine-cisplatin combination as first line therapy in treatment of pancreatic cancer
    Ozet, A.
    Satis, N. Kayahan
    Satis, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [39] Gemcitabine for the treatment of advanced nonsmall cell lung cancer
    Toschi, Luca
    Cappuzzo, Federico
    ONCOTARGETS AND THERAPY, 2009, 2 : 209 - 217
  • [40] Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer:: A randomized phase III study of the Italian lung cancer project
    Crinò, L
    Scagliotti, GV
    Ricci, S
    De Marinis, F
    Rinaldi, M
    Gridelli, C
    Ceribelli, A
    Bianco, R
    Marangolo, M
    Di Costanzo, F
    Sassi, M
    Barni, S
    Ravaioli, A
    Adamo, V
    Portalone, L
    Cruciani, G
    Masotti, A
    Ferrara, G
    Gozzelino, F
    Tonato, M
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3522 - 3530
12345